Dianthus Therapeutics | MGTA - Market Capitalization



Dianthus Therapeutics reported $723.7M in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
Alaunos Therapeutics USD 3M 2M Dec/2024
Avita Medical AUD 335.59M 29.1M Dec/2024
Cspc Pharmaceutical HKD 57.03B 1.39B Mar/2025
Dianthus Therapeutics USD 692M 93M Sep/2025
Divis Laboratories Ltd 1.81T 277.71B Jun/2025
IQVIA Holdings USD 27.26B 3.82B Jun/2025
Kangmei Pharma CNY 26.2B 2.77B Jun/2025
Knight Therapeutics CAD 599.03M 24.75M Sep/2024
Laboratorios Farma EUR 3.06B 257.39M Sep/2025
Moderna USD 10.67B 290M Jun/2025
Neuren Pharmaceuticals AUD 1.6B 1.12B Dec/2024
Organigram Holdings CAD 222.95M 23.4M Sep/2025
Organon & Co USD 2.41B 108.26M Sep/2025
Pharma Mar EUR 1.39B 91.01M Jun/2025
Qiagen NV EUR 10.41B 2.39B Jun/2025
Revvity USD 11.53B 1.18B Jun/2025
Sartorius EUR 13.56B 794.37M Jun/2025
Tectonic Therapeutic USD 377M 6M Sep/2025
Tilray CAD 647.69M 211.12M Aug/2025
Viatris USD 10.48B 83.95M Jun/2025
Xeris Pharmaceuticals USD 1.1B 347M Sep/2025
Zz Pientze Pharmaceu 120.67B 1.25B Jun/2025